Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 trial of oral tolvaptan in hemodialysis/hemodiafiltration patients with chronic renal failure
jRCT2080222704Phase 2
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of tolvaptan in chronic kidney disease (CKD) (3 arms), sponsored by Otsuka Pharmaceutical Co., Ltd.
02
Drugs
tolvaptan
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080222704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222704.